The startups will pitch in front of international investors, corporate partners and the EIT Community’s networks. The event will host more than 200 attendees, including startups, international investors, corporate partners, as well as members of the EIT Community. Three keynote addresses will also be delivered at the event from innovation leaders.
Finalists include DiabTrend, with a properly personalized therapy for diabetic patients, with which they can see how their blood glucose level will change in the future, as well as HepC Inc., which is developing an all-oral cure for hepatitis patients suffering from decompensated disease resistant to all currently available therapies.
The event will take place at the Hilton Budapest (1014 Budapest, Hess András tér 1-3), running from 9 a.m. until 5.30 p.m. this Friday, November 16.
The European Institute of Innovation & Technology (EIT) is an independent EU body set up in 2008 to promote innovation and entrepreneurship across Europe. Further information and registration for the event is available on EITʼs official website.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
